During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

But it's not all bad news. A PET scan of a female patient with breast cancer, which has spread to the lymph nodes, bones and liver. In its recent annual report, the American Cancer Society shared ...

Novellia, Inc., the AI health data platform trusted by leading biopharma companies to uncover hidden insights in real-world patient data, today announced that its CEO and co-founder Shashi Shankar has ...

A supplemental podcast curriculum improved hematology-oncology fellows’ comfort with and knowledge of medical topics, according to study results presented at ASCO Annual Meeting.The findings support ...

Download to gain expert insights and data-driven analysis from the ASCO 2025 Annual Meeting. This report covers key therapeutic advances, standout presentations, emerging trends in oncology treatment, ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...